Hologic, Inc. (HOLX)
Company Info
| ISIN | US4364401012 |
|---|---|
| CUSIP | 436440101 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| IPO Date | Jun 21, 1990 |
Highlights
| Market Cap | $19.45B |
|---|---|
| EPS (TTM) | $2.93 |
| PE Ratio | 28.57 |
| PEG Ratio | 1.31 |
| Total Revenue (TTM) | $3.04B |
| Gross Profit (TTM) | $1.70B |
| EBITDA (TTM) | $851.40M |
| Year Range | $66.93 - $84.67 |
| Target Price | $88.51 |
| Short % | 3.76% |
| Short Ratio | 4.12 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: HOLX vs. ZBH, HOLX vs. FAT, HOLX vs. VOO, HOLX vs. MDT, HOLX vs. BRK-B, HOLX vs. ISRG, HOLX vs. CHD, HOLX vs. LLY, HOLX vs. PFE, HOLX vs. AMAGX
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Hologic, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Hologic, Inc. had a return of 17.17% year-to-date (YTD) and 21.92% in the last 12 months. Over the past 10 years, Hologic, Inc. had an annualized return of 12.35%, outperforming the S&P 500 benchmark which had an annualized return of 10.92%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 17.17% | 19.77% |
| 1 month | 4.34% | -0.67% |
| 6 months | 10.26% | 10.27% |
| 1 year | 21.92% | 31.07% |
| 5 years (annualized) | 11.55% | 13.22% |
| 10 years (annualized) | 12.35% | 10.92% |
Monthly Returns
The table below presents the monthly returns of HOLX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 4.18% | -0.86% | 5.64% | -2.81% | -2.63% | 0.64% | 9.91% | -0.45% | 0.27% | -0.72% | 17.17% | ||
| 2023 | 8.77% | -2.13% | 1.33% | 6.58% | -8.28% | 2.64% | -1.91% | -5.89% | -7.14% | -4.65% | 7.75% | 0.21% | -4.49% |
| 2022 | -8.25% | 1.32% | 7.94% | -6.29% | 4.56% | -7.93% | 3.00% | -5.35% | -4.50% | 5.08% | 12.33% | -1.77% | -2.29% |
| 2021 | 9.47% | -9.58% | 3.18% | -11.87% | -3.80% | 5.80% | 12.47% | 5.48% | -6.75% | -0.68% | 1.94% | 2.45% | 5.12% |
| 2020 | 2.51% | -11.96% | -25.51% | 42.74% | 5.79% | 7.55% | 22.42% | -14.42% | 11.30% | 3.54% | 0.45% | 5.35% | 39.49% |
| 2019 | 8.03% | 6.19% | 2.65% | -4.17% | -5.11% | 9.11% | 6.73% | -3.67% | 2.27% | -4.32% | 6.23% | 1.73% | 27.03% |
| 2018 | -0.12% | -9.06% | -3.79% | 3.83% | -2.32% | 4.91% | 7.95% | -7.34% | 3.07% | -4.86% | 13.90% | -7.45% | -3.86% |
| 2017 | 1.02% | 0.12% | 4.85% | 6.11% | -4.08% | 4.78% | -2.58% | -12.69% | -4.95% | 3.16% | 10.22% | 2.47% | 6.56% |
| 2016 | -12.28% | 2.03% | -0.38% | -2.64% | 2.44% | 0.55% | 11.24% | -0.18% | 1.07% | -7.26% | 6.30% | 4.81% | 3.70% |
| 2015 | 13.56% | 6.64% | 1.99% | 2.17% | 6.02% | 6.40% | 9.46% | -6.84% | 0.82% | -0.69% | 3.83% | -4.11% | 44.69% |
| 2014 | -4.43% | 1.97% | -1.29% | -2.40% | 16.46% | 3.72% | 2.84% | -4.60% | -2.17% | 7.64% | 2.33% | -0.22% | 19.64% |
| 2013 | 19.14% | -8.47% | 3.57% | -9.89% | 1.89% | -6.99% | 17.62% | -5.99% | -3.23% | 8.35% | 0.07% | -0.18% | 11.69% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of HOLX is 78, placing it in the top 22% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Hologic, Inc. (HOLX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Hologic, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Hologic, Inc. was 93.75%, occurring on Oct 21, 1999. Recovery took 1478 trading sessions.
The current Hologic, Inc. drawdown is 4.51%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -93.75% | Jun 26, 1996 | 839 | Oct 21, 1999 | 1478 | Sep 8, 2005 | 2317 |
| -87.61% | Jul 17, 1990 | 862 | Dec 15, 1993 | 480 | Nov 8, 1995 | 1342 |
| -73.65% | Dec 27, 2007 | 301 | Mar 9, 2009 | 1567 | May 29, 2015 | 1868 |
| -46.24% | Jan 30, 2020 | 37 | Mar 23, 2020 | 62 | Jun 19, 2020 | 99 |
| -35.83% | Apr 3, 2006 | 49 | Jun 12, 2006 | 160 | Jan 31, 2007 | 209 |
Volatility
Volatility Chart
The current Hologic, Inc. volatility is 4.30%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Hologic, Inc. compared to its peers in the Medical Instruments & Supplies industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for HOLX in comparison to other companies of the Medical Instruments & Supplies industry. Currently, HOLX has a PE value of 28.6. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for HOLX in comparison to other companies of the Medical Instruments & Supplies industry. Currently, HOLX has a PEG value of 1.3. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Hologic, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |